Strides partners with Kenox to expand nasal spray portfolio for US market
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
The facility will be positioned as a Centre of Excellence for tertiary care services
Consolidated revenue from operations in the quarter was marginally down at Rs 738 crore a
Mehta brings strong leadership experience in biopharmaceuticals, life science research, and diagnostics
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Subscribe To Our Newsletter & Stay Updated